AtriCure, Inc. provided financial guidance for the full year 2022. Full year 2022 revenue is projected to be approximately $318 million to $330 million, reflecting growth of approximately 16% to 20% over full year 2021.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.5 USD | +0.33% | -0.53% | -37.18% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.18% | 1.08B | |
-2.26% | 187B | |
+2.05% | 110B | |
-1.31% | 69.54B | |
+14.65% | 46.37B | |
-6.69% | 46.05B | |
+7.97% | 42.54B | |
+18.60% | 30.72B | |
+17.70% | 25.62B | |
-6.87% | 23.32B |
- Stock Market
- Equities
- ATRC Stock
- News AtriCure, Inc.
- AtriCure, Inc. Provides Financial Guidance for the Full Year 2022